Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Sales | 1,077.27 | 926.07 | 1,085.29 | 945.18 | 1,014.58 |
| Operating profit | 315.83 | 227.15 | 327.18 | 273.65 | 276.90 |
| Interest | 0.72 | 1.42 | 2.36 | 2.27 | 0.75 |
| Gross profit | 343.48 | 259.41 | 338.55 | 323.54 | 307.61 |
| EPS (Rs) | 18.83 | 12.88 | 17.42 | 16.81 | 16.78 |
Quarterly
results in details
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Other income | 28.37 | 33.68 | 13.73 | 52.16 | 31.46 |
| Stock adjustment | -25.08 | -59.42 | 31.01 | -28.16 | 34.40 |
| Raw material | 238.41 | 259.03 | 239.04 | 223.55 | 217.81 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 265.68 | 215.97 | 216.41 | 205.48 | 196.30 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 282.43 | 283.34 | 271.65 | 270.66 | 289.17 |
| Provisions made | - | - | - | - | - |
| Depreciation | 32.92 | 33.47 | 33.41 | 33.04 | 32.24 |
| Taxation | 74.53 | 63.25 | 84.99 | 78.14 | 63.33 |
| Net profit / loss | 236.03 | 162.69 | 220.15 | 212.36 | 212.04 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 25.07 | 25.27 | 25.27 | 25.27 | 25.27 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 29.32 | 24.53 | 30.15 | 28.95 | 27.29 |
| GPM (%) | 31.07 | 27.03 | 30.80 | 32.44 | 29.41 |
| NPM (%) | 21.35 | 16.95 | 20.03 | 21.29 | 20.27 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis